Therapeutic Asset Ratings
297 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Decitabine
Adult Acute Myeloblastic Leukemia Without Maturation (M1)
Roswell Park Cancer Institute
P3
BB
(66)
Decitabine
Adult Acute Myelomonocytic Leukemia (M4)
Roswell Park Cancer Institute
P3
BB
(66)
Inno-206
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P3
BB
(66)
Cyclophosphamide
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(66)
Cyclophosphamide
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(66)
Cyclophosphamide
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(66)
Pembrolizumab
Diffuse Large B Cell Lymphoma
Roswell Park Cancer Institute
P2
BB
(66)
TESTOSTERONE UNDECYLATE
Localized Prostate Carcinoma
Roswell Park Cancer Institute
P4
BB
(65)
Cyclophosphamide
Anatomic Stage 0 Breast Cancer AJCC v8
Roswell Park Cancer Institute
P3
BB
(65)
Pembrolizumab
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P3
BB
(65)
Enzalutamide
PSA Progression
Roswell Park Cancer Institute
P2
BB
(65)
Epirubicin
High Grade Ovarian Serous Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(65)
Epirubicin
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(65)
Evomela
Adult Acute Lymphoblastic Leukemia in Remission
Roswell Park Cancer Institute
P2
BB
(65)
Fludarabine
Wiskott-Aldrich Syndrome
Roswell Park Cancer Institute
P2
BB
(65)
Pembrolizumab
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2
BB
(65)
Recombinant Human EGF-rP64K
Lung Non-Small Cell Carcinoma
Roswell Park Cancer Institute
P2
BB
(65)
Recombinant Human EGF-rP64K
Stage III Lung Cancer AJCC v8
Roswell Park Cancer Institute
P2
BB
(65)
TEONANACATL
Hematopoietic and Lymphatic System Neoplasm
Roswell Park Cancer Institute
P2
BB
(65)
Epirubicin
Colorectal Carcinoma
Roswell Park Cancer Institute
P3
BB
(64)
INTERFERON ALFA-2B
Melanoma
Roswell Park Cancer Institute
P3
BB
(64)
Pembrolizumab
Colorectal Carcinoma
Roswell Park Cancer Institute
P3
BB
(64)
Adagrasib
Malignant Neoplasm of Lung
Roswell Park Cancer Institute
P2
BB
(64)
Decitabine
Advanced Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P2
BB
(64)
Epirubicin
Richter Syndrome
Roswell Park Cancer Institute
P2
BB
(64)
Showing 26 to 50 of 297 assets
Previous
Page 2 of 12
Next